iNCOVACC: All you need to know about world's first intranasal Covid vaccine

The vaccine been approved for use as a primary as well as a heterologous (mix-and-match) booster dose in India

BS Web Team New Delhi
Bharat Biotech’s iNCOVACC, Bharat Bio’s nasal Covid vaccine, nasal Covid vaccine, Covid vaccine

iNCOVACC (BBV154) is India's first intranasal Covid-19 vaccine, and can be used for easy and painless immunisation against coronavirus.

India launched its first intranasal Covid-19 vaccine named iNCOVACC, on Thursday, January 26. Manufactured by Hyderabad-based Bharat Biotech, the intranasal vaccine was launched by Union Health Minister Mansukh Mandaviya and Union Minister of Science & Technology Jitendra Singh on India's 74th Republic Day.
The vaccine has been approved for use as a primary as well as a heterologous (mix-and-match) booster dose in India.
Here's everything you need to know about India's first intranasal vaccine for coronavirus:

Also Read

Nasal vaccines for Covid-19: How do they work and what are their benefits?

Bharat Biotech awaits booster dose nod for intranasal vaccine iNCOVACC

What are nasal vaccines and how do they work?

Bharat Biotech rolls out India's first intra-nasal Covid vaccine iNCOVACC

Bharat Biotech says Phase 3 trial over, intranasal vaccine 'safe'

India records 99 new Covid-19 cases, active count declines to 1,896

Health Minister Mandaviya launches Bharat Biotech's nasal Covid-19 vaccine

India reports 132 new coronavirus cases, active tally decline to 1,906

Booster dose of Covishield offers best immune response: Lancet study

India records 102 new coronavirus cases, active tally dips to 1,922

First Published: Jan 27 2023 | 5:17 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers. Already a BS Premium subscriber?LOGIN NOW

Register to